The global pharmacogenomics market is witnessing a remarkable expansion, with a current valuation of USD 8.69 billion in 20231. It is anticipated to reach USD 19.74 billion by 20311, showcasing a Compound Annual Growth Rate (CAGR) of 10.80%1. This surge is primarily attributed to the increasing integration of pharmacogenomics in personalized medicine and drug development. Consequently, it becomes imperative for leaders in the pharmaceutical and healthcare industries to grasp the nuances of global pharmacogenomics market trends and pharmacogenomics industry analysis.
The pharmacogenomics sector is undergoing a transformative phase, necessitating a keen awareness of the latest advancements and trends. The escalating rates of adverse drug reactions and the rising prevalence of various disorders are pivotal drivers of market expansion1. Furthermore, the sector is witnessing a surge in research and development investments, with industry gian...
_____
If you are a member of our Association, please log in below to continue reading our exclusive content.
Not a member yet? Discover the benefits of joining our network and gain access to exclusive content like this for only $29.95 per month. Learn More and Sign Up
